Hudson Bay Capital Management’s Pfizer PFE Stock Holding History

Hudson Bay Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-178,900	Closed	-$4.34M	–	1577
2025 Q2	$4.34M	Buy	178,900 +157,000	+717%	+$3.66M	0.01%	578
2025 Q1	$555K	Sell	21,900 -1,978,100	-99%	-$51.8M	﹤0.01%	1019
2024 Q4	$53.1M	Sell	2,000,000 -1,555,000	-44%	-$42.2M	0.19%	118
2024 Q3	$103M	Sell	3,555,000 -1,445,000	-29%	-$42.2M	0.42%	47
2024 Q2	$140M	Buy	+5,000,000	New	+$138M	0.66%	38
2023 Q2	–	Sell	-2,000,000	Closed	-$81.6M	–	939
2023 Q1	$81.6M	Buy	+2,000,000	New	+$86.4M	0.67%	45
2022 Q3	–	Sell	-75,000	Closed	-$3.93M	–	1322
2022 Q2	$3.93M	Buy	+75,000	New	+$3.82M	0.03%	545
2019 Q3	–	Sell	-2,740,400	Closed	-$113M	–	467
2019 Q2	$113M	Sell	2,740,400 -2,740,400	-50%	-$109M	2.58%	8
2019 Q1	$221M	Buy	+5,480,800	New	+$219M	2.85%	5
2017 Q2	–	Sell	-76,520	Closed	-$2.48M	–	723
2017 Q1	$2.48M	Buy	+76,520	New	+$2.41M	0.03%	413

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Hudson Bay Capital Management's PFE Position: Q1 2026 in Review

Hudson Bay Capital Management reduced its Pfizer (PFE) stake by 49% in Q1 2026, selling an estimated $2.26M and leaving 90,000 shares worth $2.53M. The position accounts for 0.01% of the portfolio, ranked #709.

Hudson Bay Capital Management first reported a position in PFE in Q4 2015 and has held it in 20 quarters since. The position peaked at $142M in Q2 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Hudson Bay Capital Management held 90,000 shares of Pfizer worth $2.53M as of Q1 2026.
Hudson Bay Capital Management sold 85,000 Pfizer shares in Q1 2026, an estimated $2.26M.
Pfizer made up 0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #709 holding.
Hudson Bay Capital Management first reported a position in Pfizer in Q4 2015 and has held it in 20 quarters since.
Hudson Bay Capital Management's Pfizer position peaked at $142M in Q2 2024.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.